Dina is a director in 3i’s Growth Capital healthcare team, with strong sector and operating experience across growth and venture capital. Her recent investments include EUSA Pharma, a transatlantic specialty pharmaceutical company, Endosense, a cardiovascular medical device business, and Novexel, a spin-out of the Sanofi-Aventis anti-infective unit. With a PhD in molecular biology, Dina has previously worked at Index Ventures (Geneva), the Pasteur Institute (Paris), France and the Fox-Chase Cancer Centre (Philadelphia). Print this page